Skip to main content
. 2021 Jul 28;12(8):747. doi: 10.1038/s41419-021-04024-9

Fig. 5. Pathological features of exosomal miR-1260b in NSCLC.

Fig. 5

A Exosomal miR-1260b expression in the plasma of healthy donors (n = 48) and patients with NSCLC (n = 48). B Expression levels of exosomal miR-1260b were analyzed according to different stages, including C early (I–II) and late (III–IV) stage or D metastatic and nonmetastatic stages of NSCLC. E Kaplan–Meier survival curve stratified by high and low exosomal miR-1260b expression levels. *P < 0.05, **P < 0.005, ***P < 0.0005.